However, pioglitazone inhibited the production of mitochondrial ROS in CKD-MSCs and PrPC knockdown suppressed the protective effect of pioglitazone against ER stress-induced oxidative stress (Figure 3E). This evidence concerns the gene PRNP and chronic kidney disease.